|Articles|May 1, 2018
- Pharmaceutical Executive-05-01-2018
- Volume 38
- Issue 5
Pharmaceutical Executive, May 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Brands of the Year: Promise and Challengeover 7 years ago
Gauging the Collaborative Spirit in European Healthover 7 years ago
Gottlieb Tackles Drug Competition & Costsover 7 years ago
Deploying the Cloud in GxP Environmentsover 7 years ago
So Much Depends on the Physicianover 7 years ago
Bridging Science & Strategy: An Investor’s Eyeover 7 years ago
Patient Empowerment and the Future of Pharma Advertisingover 7 years ago
Closing Pharma’s Digital Divideover 7 years ago
Patient KOLs: Their Guide to Entering Crowded Marketsover 7 years ago
The Total Care PackageNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
